Company Overview and News

6
[Press] CNOOC Limited Announces Changes in Directors

2018-04-30 oilvoice
CNOOC Limited (the "Company", SEHK: 00883, NYSE: CEO, TSX: CNU) has announced changes in directors of the Company. Mr. Wang Dongjin has been appointed as a Non-executive Director and a member of the Remuneration Committee of the Company. Mr. Wu Guangqi has resigned as a Non-executive Director and a member of the Remuneration Committee of the Company due to retirement. The aforementioned changes take effect from 27 April 2018.
CNU CEO

6
[Press] CNOOC Limited Announces Pricing of Guaranteed Notes Offering

2018-04-26 oilvoice
HONG KONG, April 25, 2018 /PRNewswire/ -- CNOOC Limited (the "Company", NYSE: CEO, SEHK: 00883, TSX: CNU) announced on April 25, 2018 (New York time) the pricing of an offering of US$ 1,450,000,000 aggregate principal amount of guaranteed notes. The offering consists of US$450,000,000 of 3.750% guaranteed notes due 2023 (the "2023 Notes") and US$1,000,000,000 of 4.375% guaranteed notes due 2028 (the "2028 Notes").
CNU CEO

6
[Press] CNOOC Limited Announces Key Operational Statistics for Q1 2018

2018-04-20 oilvoice
(Hong Kong, April 20, 2018) - CNOOC Limited (the “Company”, SEHK: 00883, NYSE: CEO, TSX: CNU) today announced its key operational statistics for the first quarter of 2018.
CNU CEO

6
[Press] CNOOC Limited: Reserve and Profit Significantly Increased, Net Profit Greatly Improved

2018-03-29 oilvoice
HONG KONG, March 29, 2018 /PRNewswire/ -- CNOOC Limited (the "Company") (SEHK: 00883) (NYSE: CEO) (TSX: CNU) today announced its 2017 annual results for the year ended December 31, 2017.
CNU CEO

6
[Press] CNOOC Limited Announces Weizhou 6-13 Oilfield Commences Production

2018-03-20 oilvoice
(Hong Kong, March 20, 2018) - CNOOC Limited (the “Company”, SEHK: 00883, NYSE: CEO, TSX: CNU) announced today that Weizhou 6-13 oilfield has commenced production ahead of schedule. Weizhou 6-13 oilfield is located in Beibu Gulf in the South China Sea with an average water depth of approximately 35 meters. In addition to fully utilizing the existing facilities of Weizhou 12-1 oilfield, the project has also built one wellhead platform.
CNU CEO

Related Articles

HIMX: Himax Technologies Analysis and Research Report

3h - Asif

History and Development Himax Taiwan, its predecessor, was incorporated on June 12, 2001 as a limited liability company under the laws of the ROC. On April 26, 2005, the company established Himax Technologies Limited, an exempted company with limited liability under the Cayman Islands Companies Law, as a holding company to hold the shares of Himax Taiwan in connection with its reorganization and share exchange. On October 14, 2005, Himax Taiwan became its wholly owned subsidiary through a share exchange consummated pursuant to the ROC Business Mergers and Acquisitions Law through which the company acquired all of the issued and outstanding shares of Himax Taiwan, and the company issued ordinary shares to the shareholders of Himax Taiwan. Shareholders of Himax Taiwan received one of its ordinary shares in exchange for one Himax Taiwan common share. The share exchange was unanimously approved by shareholders of Himax Taiwan on June 10, 2005 with no dissenting shareholders and by ...

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

Silicon Investor Message Boards

This table lists all message boards related to TSX:CNU / Cnooc Limited on message board site Silicon Investor.

Continucare (CNU) depr. PSYCLE sm buy again ?